As of close of business last night, Longboard Pharmaceuticals Inc’s stock clocked out at $19.32, up 2.28% from its previous closing price of $18.89. In other words, the price has increased by $+0.43 from its previous closing price. On the day, 2500144 shares were traded.
Ratios:
To gain a deeper understanding of LBPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.14 and its Current Ratio is at 5.14. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on February 16, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On April 27, 2023, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $13.B. Riley Securities initiated its Buy rating on April 27, 2023, with a $13 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 25 ’24 when ARENA PHARMACEUTICALS INC sold 3,978,540 shares for $24.25 per share. The transaction valued at 96,479,595 led to the insider holds 0 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LBPH now has a Market Capitalization of 693.33M and an Enterprise Value of 645.31M.
Stock Price History:
Over the past 52 weeks, LBPH has reached a high of $28.15, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is 21.97, while the 200-Day Moving Average is calculated to be 10.17.
Shares Statistics:
It appears that LBPH traded 1.47M shares on average per day over the past three months and 719.41k shares per day over the past ten days. A total of 38.44M shares are outstanding, with a floating share count of 35.60M. Insiders hold about 7.38% of the company’s shares, while institutions hold 51.04% stake in the company. Shares short for LBPH as of Feb 29, 2024 were 3.19M with a Short Ratio of 2.17, compared to 2.44M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.01% and a Short% of Float of 12.39%.
Earnings Estimates
As of right now, 7 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.51 for the current quarter, with a high estimate of -$0.37 and a low estimate of -$0.67, while EPS last year was -$0.56. The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.37 and low estimates of -$0.55.
Analysts are recommending an EPS of between -$1.52 and -$2.39 for the fiscal current year, implying an average EPS of -$1.98. EPS for the following year is -$2.45, with 8 analysts recommending between -$1.96 and -$2.86.
